Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differential U2AF1 mutation sites, burden and co-mutation genes can predict prognosis in patients with myelodysplastic syndrome.

Scientific reports - 29 Oct 2020

Wang Haiqiong, Guo Yongbo, Dong Zhenkun, Li Tao, Xie Xinsheng, Wan Dingming, Jiang Zhongxing, Yu Jifeng, Guo Rong

Abstract excerpt

To investigate the U2AF1 gene mutation site, mutation load and co-mutations genes in patients with myelodysplastic syndrome (MDS) and their effects on prognosis. Gene mutation detection by next-generation sequence and related clinical data of 234 MDS patients were retrospectively collected and analyzed for the relationship between the clinical characteristics, treatment efficacy and prognosis of U2AF1 gene...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Disease Progression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Myelodysplastic Syndromes

Share to Nucleophosmin

Share to Prognosis

Share to Splicing Factor U2AF

Share to Survival Analysis

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 33122737
DOI: 10.1038/s41598-020-74744-z
PMCID: PMC7596495

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differential U2AF1 mutation sites, burden and co-mutation genes can predict prognosis in patients with myelodysplastic syndrome.PMID 33122737Read ↗

Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression.Semantic proximity Read ↗

Analysis of gene mutation characteristics and its correlation with prognosis in patients with myelodysplastic syndromes.Semantic proximity Read ↗

[Clinical analysis of gene mutation characteristics and mutation burden in myelodysplastic syndrome].Semantic proximity Read ↗

[The Correlation of Gene Mutation and Clinical Characteristics in Patients with Myelodysplastic Syndrome and Prognostic Analysis].Semantic proximity Read ↗

[Correlation between U2AF1 Gene Mutation Characteristics and Clinical Manifestations and Prognosis in Patients with Myelodysplastic Syndrome].Semantic proximity Read ↗

U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity.Semantic proximity Read ↗

Prognostic impact of DTA mutation and co-occurring mutations in patients with myelodysplastic syndrome.Semantic proximity Read ↗

The Biological and Clinical Consequences of RNA Splicing Factor U2AF1 Mutation in Myeloid MalignanciesSemantic proximity Read ↗

Impact of U2AF1 Pathogenic Variants on Prognosis of Myelodysplastic Neoplasms With RUNX1 Mutation.Semantic proximity Read ↗

Co-mutation landscape and clinical significance of RAS pathway related gene mutations in patients with myelodysplastic syndrome.Semantic proximity Read ↗

Mutational landscape of patients with acute myeloid leukemia or myelodysplastic syndromes in the context of RUNX1 mutation.Semantic proximity Read ↗

Clinical characteristics and prognostic analysis of gene mutations in Myelodysplastic SyndromeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.